Vistance Networks (VISN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
A special meeting is called to approve the $10.5B cash sale of the Connectivity and Cable Solutions (CCS) segment to Amphenol, representing about 62% of current revenues and assets, with net proceeds expected to be $10B after taxes and expenses.
The board unanimously recommends approval of the sale, an advisory vote on executive compensation related to the transaction, and the right to adjourn the meeting if more votes are needed.
Proceeds will be used to repay all debt, redeem preferred equity, and a substantial portion is expected to be distributed as a special dividend to common shareholders within 90 days of closing.
The sale is expected to close in the first half of 2026, subject to regulatory and shareholder approvals.
Voting matters and shareholder proposals
Shareholders will vote on: (1) approval of the CCS Sale Proposal, (2) a non-binding advisory vote on executive compensation tied to the sale, and (3) adjournment/postponement of the meeting if needed to solicit more votes.
Approval of the sale requires a majority of outstanding stock (common and Series A Preferred, voting as a single class).
The board recommends voting FOR all three proposals.
Board of directors and corporate governance
The board conducted a comprehensive strategic review, considering over 60 potential buyers and multiple proposals, before selecting Amphenol's all-cash offer for the entire CCS business.
The board considered certainty of value, ability to pay down debt, return capital to shareholders, and the future prospects of the remaining businesses.
Key supporting stockholders, including certain directors, officers, and Carlyle Partners VII S1 Holdings, entered into voting agreements to support the sale.
Latest events from Vistance Networks
- Director elections, executive pay, auditor ratification, and incentive plan shares up for vote.VISN
Proxy filing23 Mar 2026 - Proxy outlines director elections, executive pay, auditor ratification, and major ESG progress.VISN
Proxy filing23 Mar 2026 - Core adjusted EBITDA up 176% in 2025; $10/share special distribution planned.VISN
Q4 202526 Feb 2026 - Adjusted EBITDA up nearly 20% as CCS growth offsets declines; $2.1B OWN/DAS sale to aid liquidity.VISN
Q2 20242 Feb 2026 - Core adjusted EBITDA rose 25% on strong CCS gains; OWN and DAS divestiture set for Q1 2025.VISN
Q3 202416 Jan 2026 - Core adjusted EBITDA up 159% on 23.5% sales growth; 2025 guidance reaffirmed.VISN
Q1 202524 Dec 2025 - Q4 core sales jumped 27% and margins rose, with 2025 EBITDA guidance at $1.00–$1.05B.VISN
Q4 202421 Dec 2025 - Definitive agreement to sell CCS segment to Amphenol, pending shareholder approval and regulatory review.VISN
Proxy Filing2 Dec 2025 - CCS business sale unlocks equity, enables debt repayment, and sets up a major shareholder dividend.VISN
Proxy Filing1 Dec 2025 - $10.5B sale of CCS segment to Amphenol, pending approvals and board support.VISN
Proxy Filing1 Dec 2025